Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice

P. K. Kavoussi, K. Heberlein, A. C. Straub, G. J. Lowe, J. L. Oliver, Ryan P. Smith, W. D. Steers, B. H. Annex, B. E. Isakson, J. J. Lysiak

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Myoendothelial junctions are specialised projections of cell: cell contact through the internal elastic lamina between endothelial cells and vascular smooth muscle cells. These junctions allow for endothelial cells and vascular smooth muscle cells to make direct membrane apposition and are involved in cell: cell communication. In this study, we evaluated for the presence of myoendothelial junctions in murine corporal tissue and used plasminogen activator inhibitor (PAI)-1-deficient mice, which lack myoendothelial junctions, to determine whether myoendothelial junctions affect erectile function. Transmission electron microscopy demonstrated the presence of myoendothelial junctions in the corporal tissue of wild-type mice and confirmed the decreased junction numbers in the tissue of PAI-1-/- mice. A potential role for myoendothelial junctions in tumescence was established; in that, PAI-1-/- mice demonstrated a significantly longer time to achieve maximal intracavernous pressure. Treatment of PAI-1-/- mice with recombinant PAI-1 restored the number of myoendothelial junctions in the corporal tissue and also induced a significant decrease in time to maximal corporal pressures. Myoendothelial junctions were similarly identified in the human corporal tissue. These results suggest a critical role for myoendothelial junctions in erectile pathophysiology and therapies aimed at restoring myoendothelial junction numbers in the corporal tissue may provide a novel therapy for erectile dysfunction.

Original languageEnglish (US)
Pages (from-to)1147-1152
Number of pages6
JournalAndrologia
Volume47
Issue number10
DOIs
StatePublished - Dec 2015
Externally publishedYes

Keywords

  • Cell communication
  • Endothelial cells
  • Erectile dysfunction
  • Plasminogen activators
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Endocrinology
  • Urology

Fingerprint Dive into the research topics of 'Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice'. Together they form a unique fingerprint.

  • Cite this

    Kavoussi, P. K., Heberlein, K., Straub, A. C., Lowe, G. J., Oliver, J. L., Smith, R. P., Steers, W. D., Annex, B. H., Isakson, B. E., & Lysiak, J. J. (2015). Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice. Andrologia, 47(10), 1147-1152. https://doi.org/10.1111/and.12395